Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

Russia is open to peace in Ukraine, but insists achieving its goals remains the priority. On Sunday, Kremlin spokesman Dmitry Peskov reiterated Russia’s demands, including Ukraine withdrawing from ann ...

While the North Chicago, Illinois-based healthcare giant estimated its adjusted diluted earnings per share for Q3 could reach $1.28 - $1.32 compared to $1.33 in the consensus, its full-year outlook ...